Results 191 to 200 of about 188,451 (293)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

, 2020
National Cancer Institute
openalex   +1 more source

Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia. [PDF]

Nucleic Acids Res
Sharma S, Thomas E, Dahal S, Das S, Kothari S, Roy U, Kumari N, Gopalakrishnan V, Raghavan SC.   +8 more
europepmc   +1 more source

Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells. [PDF]

PLoS One, 2023
Mitrovský O, Myslivcová D, Macháčková-Lopotová T, Obr A, Čermáková K, Ransdorfová Š, Březinová J, Klamová H, Žáčková M.   +8 more
europepmc   +1 more source

New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia [PDF]

, 1990
Giuseppe Saglio, A Guerrasio, C Rosso, Alfonso Zaccaria, A Tassinari, A. Serra, Giovanna Rege Cambrin, U Mazza, F Gavosto   +8 more
openalex   +1 more source

RETRACTED: Ouyang et al. Precision Isolation of Circulating Leukemia Cells in Chronic Myelogenous Leukemia Patients Using a Novel Microfluidic Device and Its Clinical Applications. <i>Cancers</i> 2023, <i>15</i>, 5696. [PDF]

Cancers (Basel)
Ouyang D, Ye N, Yang K, Wang Y, Hu L, Chao S, Li Y.   +6 more
europepmc   +1 more source

Brassinin Induces Apoptosis, Autophagy, and Paraptosis via MAPK Signaling Pathway Activation in Chronic Myelogenous Leukemia Cells. [PDF]

Biology (Basel), 2023
Yang MH, Ha IJ, Lee SG, Lee J, Um JY, Sethi G, Ahn KS.   +6 more
europepmc   +1 more source

Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]

Ann Med Surg (Lond)
Zhu F, Wang H, Qiu L.
europepmc   +1 more source

Pseudohypoxemia From Leukocyte Larceny in a Patient With Chronic Myelogenous Leukemia. [PDF]

Cureus, 2022
Mirzai S, Andreae M, Puttarajappa C.
europepmc   +1 more source

Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia

, 2002
Shu-Quan Ji, Hui‐Ren Chen, Hang-Xiang Wang, Hong-Ming Yan, Shi-Ping Pan, Chang-Qing Xun   +5 more
openalex   +1 more source

Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting. [PDF]

Cancer Med
Awlachew WY, Tasamma AT, Mengistie FA, Alemineh ZT, Tefera ST.   +4 more
europepmc   +1 more source